Study Reveals How Resistant Bacteria Clone Rose and Fell

Researchers at ITQB NOVA and collaborators traced a vancomycin-resistant Enterococcus faecium clone's rise and decline in a Copenhagen hospital.

Updated on Nov. 13, 2026 in Life Sciences

Bold flat-color editorial illustration of three petri dishes in a row, one crowded with cream bacterial colonies and two sparse, illustrating a bacterial clone's rise and fall.
Researchers at ITQB NOVA and collaborators traced how a vancomycin-resistant Enterococcus faecium clone spread through a Copenhagen hospital from 2012 to 2020 before declining. AI Illustration. Upload story photo >

A study published in Genome Medicine examined a vancomycin-resistant Enterococcus faecium clone that spread through a hospital setting between 2012 and 2020. Its decline was linked to the diversification of its genome and the emergence of descendants able to produce antimicrobial molecules that inhibit competitors.

Why it matters

The World Health Organization lists this bacterium among its highest-priority pathogens in its 2024 Bacterial Priority Pathogens List. Understanding how such clones persist and collapse could inform strategies to reduce their spread in hospitals worldwide.

The study followed one vancomycin-resistant Enterococcus faecium clone at Copenhagen University Hospital from 2012 to 2020, tracking its rise and subsequent decline. It remains unclear from the available findings whether the same dynamics occur across other hospitals or regions.

The players

ITQB NOVA

ITQB NOVA is the Instituto de Tecnologia Química e Biológica António Xavier, a research institute of Universidade NOVA de Lisboa in Portugal focused on chemistry and biology.

World Health Organization

The World Health Organization is the United Nations agency responsible for international public health, which publishes global priority lists of pathogens to guide research and funding.

The details

The clone dominated for years because it maintained a stable genome carrying key plasmids and accessory genes, and it rarely recombined its DNA. Its decline coincided with genomic diversification and the loss of genes tied to antibiotic resistance and alternative sugar metabolism, while some descendants gained the ability to produce bacteriocins that suppress nearby competitors.

Timeline

  1. 2012 to 2020: Period in which the clone's rise and fall were studied at Copenhagen University Hospital.

  2. 2024: The World Health Organization published its Bacterial Priority Pathogens List including this bacterium.

The Big Picture

The study adds mechanistic detail to why vancomycin-resistant Enterococcus faecium is ranked among the WHO's highest-priority pathogens in its 2024 list. It suggests that the same genetic traits enabling persistence may also create vulnerabilities that could be targeted.

Strategies aimed at the traits that helped this clone persist could eventually inform infection-control practices in hospitals. For patients, the work points toward reducing resistant bacteria in the gut and on hospital surfaces, though translation into care is not yet established.

The takeaway

Resistant bacteria can thrive through genetic stability and cooperative traits, but those same features can become liabilities. Monitoring hospital clones early, before they spread widely, remains a key challenge for infection control.

Further reading

Explore more on Life Sciences for context on how microbes adapt and persist.